Literature DB >> 18297291

Morphometry of the human substantia nigra in ageing and Parkinson's disease.

Gay Rudow1, Richard O'Brien, Alena V Savonenko, Susan M Resnick, Alan B Zonderman, Olga Pletnikova, Laura Marsh, Ted M Dawson, Barbara J Crain, Mark J West, Juan C Troncoso.   

Abstract

To investigate the relation between the loss of substantia nigra (SN) neurons in normal ageing and Parkinson's disease (PD), we measured the total number and the cell body volume of pigmented (neuromelanin) neurons in the SN. We examined young (n = 7, mean age: 19.9), middle-aged (n = 9, mean age: 50.1), and older controls from the Baltimore Longitudinal Study of Aging (n = 7, mean age: 87.6), as well as PD cases (n = 8, mean age: 74.8). On random-systematically selected paraffin Nissl-stained sections, we used the Optical Fractionator to estimate the total number of neurons on one side of the SN. Using the Nucleator probe, we measured the volume of these neurons. In young and older controls, we also estimated the total number and volume of tyrosine hydroxylase (TH) positive (+) nigral neurons. We observed a significant loss of pigmented (-28.3%, P < 0.01) and TH (+) (-36.2%, P < 0.001) neurons in older controls compared with younger subjects. Analysis of the size distribution of pigmented and TH (+) neurons showed a significant hypertrophy in older controls compared to young controls (P < 0.01). In contrast, in PD we observed a significant atrophy of pigmented neurons compared to all control groups (P < 0.01). These data suggest that neuronal hypertrophy represents a compensatory mechanism within individual SN neurons that allows for normal motor function despite the loss of neurons in normal ageing. Presumably, this compensatory mechanism breaks down or is overwhelmed by the pathological events of PD leading to the onset of the characteristic motor disturbances.

Entities:  

Mesh:

Year:  2008        PMID: 18297291      PMCID: PMC2431149          DOI: 10.1007/s00401-008-0352-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  48 in total

1.  alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.

Authors:  E Braak; D Sandmann-Keil; U Rüb; W P Gai; R A de Vos; E N Steur; K Arai; H Braak
Journal:  Acta Neuropathol       Date:  2001-03       Impact factor: 17.088

Review 2.  The pathology of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Adv Neurol       Date:  2001

3.  Aging and extrapyramidal function.

Authors:  P L McGeer; E G McGeer; J S Suzuki
Journal:  Arch Neurol       Date:  1977-01

Review 4.  Histological changes of the dopaminergic nigrostriatal system in aging.

Authors:  A K Stark; B Pakkenberg
Journal:  Cell Tissue Res       Date:  2004-09-08       Impact factor: 5.249

5.  Where does parkinson disease pathology begin in the brain?

Authors:  Kelly Del Tredici; Udo Rüb; Rob A I De Vos; Jürgen R E Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-05       Impact factor: 3.685

6.  Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).

Authors:  Irina Mikolaenko; Olga Pletnikova; Claudia H Kawas; Richard O'Brien; Susan M Resnick; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2005-02       Impact factor: 3.685

7.  Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy.

Authors:  C R Cabello; J J Thune; H Pakkenberg; B Pakkenberg
Journal:  Neuropathol Appl Neurobiol       Date:  2002-08       Impact factor: 8.090

Review 8.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

9.  Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.

Authors:  Yaping Chu; Katie Kompoliti; Elizabeth J Cochran; Elliott J Mufson; Jeffrey H Kordower
Journal:  J Comp Neurol       Date:  2002-08-26       Impact factor: 3.215

Review 10.  Alzheimer disease and cerebrovascular pathology: an update.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

View more
  63 in total

1.  Mosaic aging.

Authors:  Lary C Walker; James G Herndon
Journal:  Med Hypotheses       Date:  2010-01-27       Impact factor: 1.538

2.  Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention.

Authors:  Michael F Salvatore; Jennifer Terrebonne; Mark A Cantu; Tamara R McInnis; Katy Venable; Parker Kelley; Ella A Kasanga; Brian Latimer; Catherine L Owens; Brandon S Pruett; Yongmei Yu; Robert Luedtke; Michael J Forster; Nathalie Sumien; Donald K Ingram
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-12-12       Impact factor: 6.053

3.  The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons.

Authors:  P R Mouton; B Kelley-Bell; D Tweedie; E L Spangler; E Perez; O D Carlson; R G Short; R deCabo; J Chang; D K Ingram; Y Li; N H Greig
Journal:  Neurobiol Aging       Date:  2010-11-19       Impact factor: 4.673

4.  Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).

Authors:  Richard J O'Brien; Susan M Resnick; Alan B Zonderman; Luigi Ferrucci; Barbara J Crain; Olga Pletnikova; Gay Rudow; Diego Iacono; Miguel A Riudavets; Ira Driscoll; Donald L Price; Lee J Martin; Juan C Troncoso
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 5.  Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?

Authors:  I Driscoll; J Troncoso
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

6.  Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.

Authors:  Cecilia Bove; Laura Anselmi; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-05-01       Impact factor: 4.052

7.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

8.  Three-dimensional and stereological characterization of the human substantia nigra during aging.

Authors:  Ana Tereza Di Lorenzo Alho; Claudia Kimie Suemoto; Lívia Polichiso; Edilaine Tampellini; Kátia Cristina de Oliveira; Mariana Molina; Glaucia Aparecida Bento Santos; Camila Nascimento; Renata Elaine Paraizo Leite; Renata Eloah de Lucena Ferreti-Rebustini; Alexandre Valotta da Silva; Ricardo Nitrini; Carlos Augusto Pasqualucci; Wilson Jacob-Filho; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  Brain Struct Funct       Date:  2015-09-19       Impact factor: 3.270

9.  Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine.

Authors:  Michael F Salvatore; Jennifer Terrebonne; Victoria Fields; Danielle Nodurft; Cori Runfalo; Brian Latimer; Donald K Ingram
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

10.  Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.

Authors:  Michael F Salvatore; Brandon S Pruett; Sandy L Spann; Charles Dempsey
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.